Skip to Main Content

Paper Details

Metabolomic profiling for dyslipidemia in pediatric patients with sickle cell disease, on behalf of the IHCC consortium.
Metabolomics
3
2022
Author NameAffiliation
Joseph T GlessnerThe Center for Applied Genomics, Children's Hospital of Philadelphia
Joseph T GlessnerChildren's Hospital of Philadelphia
Joseph T GlessnerThe Perelman School of Medicine, University of Pennsylvania
Frank D MentchThe Center for Applied Genomics, Children's Hospital of Philadelphia
Frank D MentchThe Center for Applied Genomics, Children's Hospital of Philadelphia
Patrick M A SleimanThe Center for Applied Genomics, Children's Hospital of Philadelphia
Patrick M A SleimanChildren's Hospital of Philadelphia
Patrick M A SleimanThe Perelman School of Medicine, University of Pennsylvania
Patrick M A SleimanThe Center for Applied Genomics, Children's Hospital of Philadelphia
Patrick M A SleimanThe Perelman School of Medicine, University of Pennsylvania
Patrick M A SleimanChildren's Hospital of Philadelphia
John J ConnollyThe Center for Applied Genomics, Children's Hospital of Philadelphia
Hakon HakonarsonThe Center for Applied Genomics, Children's Hospital of Philadelphia
Hakon HakonarsonThe Perelman School of Medicine, University of Pennsylvania
Hakon HakonarsonChildren's Hospital of Philadelphia
Hakon HakonarsonChildren's Hospital of Philadelphia
Hakon HakonarsonUniversity of Iceland
Hakon HakonarsonThe Center for Applied Genomics, Children's Hospital of Philadelphia
Hakon HakonarsonThe Perelman School of Medicine, University of Pennsylvania
Hakon HakonarsonChildren's Hospital of Philadelphia
Hakon HakonarsonChildren's Hospital of Philadelphia
Hakon HakonarsonUniversity of Iceland
  • 1 - 22

Datasets